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ABSTRACT 
Aromatase, a key steroidogenic enzyme that catalyses the conversion of androgens to 
estrogens, represent a target for endocrine disrupting chemicals. However, little is known 
about the effect of pollutants on aromatase enzymes in fish. In this study, we first optimised a 
rainbow trout (Oncorhynchus mykiss) microsomal aromatase assay to measure the effects of 
43 substances belonging to diverse chemical classes (steroidal and non steroidal aromatase 
inhibitors, pesticides, heavy metals, organotin compounds, dioxins, polycyclic aromatic 
hydrocarbons) on brain and ovarian aromatase activities in vitro. Our results showed that 12 
compounds were able to inhibit brain and ovarian aromatase activities in a dose-dependent 
manner with IC50 values ranging from the low nM to the high µM range depending on the 
substance: steroidal and non steroidal inhibitors of aromatase (4-hydroxyandrostenedione, 
androstatrienedione, aminogluthethimide), imidazole fungicides (clotrimazole, imazalil, 
prochloraz), triazole fungicides (difenoconazole, fenbuconazole, propiconazole, triadimenol), 
the pyrimidine fungicide fenarimol and methylmercury. Overall, this study demonstrates that 
rainbow trout brain and ovarian microsomal aromatase assay is suitable for evaluating 
potential aromatase inhibitors in vitro notably with respect to environmental screening. The 
results highlight that methylmercury and some pesticides that are currently used throughout 









It has now been well established that many environmental pollutants are able to 
disturb the normal physiology and endocrinology of organisms. These substances, termed 
Endocrine Disrupting Chemicals (EDCs), have been defined as “exogenous substances that 
cause adverse health effects in an intact organism, or its progeny, secondary to changes in 
endocrine function” (OECD,1997). Exposure of fish to EDCs has been associated with 
reproductive adverse effects at both individual and population level in a variety of fish species 
(Jobling et al., 2002; Brion et al., 2004; Nash et al., 2004; Mills and Chichester, 2005). These 
substances have multiple modes of action since they can potentially act on the synthesis, 
secretion, transport, action and elimination of endogenous hormones (Segner et al., 2003). To 
date, research has focused mainly on compounds that interfere with sex steroids receptors, 
particularly the estrogen receptor. However, the endocrine system may also be disrupted by 
environmental substances through pathways and mechanisms other than those that are ER-
mediated. The knowledge of critical molecular and biochemical targets of EDCs in fish is thus 
of a great interest.  
The biosynthesis of steroid hormones represents  a target for EDC action, particularly 
the steps catalysed by cytochrome P450-dependent enzymes (Monod et al., 1993). In 
vertebrates, an essential sex-related enzyme is aromatase (P450aro). Aromatase is an 
enzymatic complex including a NADPH-dependent cytochrome P450 reductase and a 
cytochrome P450 aromatase which catalyzes the final, rate-limiting step in the conversion of 
androgens into estrogens (Simpson et al., 1994). In fish, this enzyme has been shown to be 
mainly expressed in ovary and brain. In mammals except pig, only one gene encodes the 
aromatase while in several teleost fish such as zebrafish (Danio rerio), goldfish (Carassius 
auratus) or rainbow trout (Oncorhynchus mykiss), aromatase is encoded by two different 
genes : cyp19a (or cyp19A1) and cyp19b (cyp19A2) (Callard and Tchoudakova, 1997; 
Kishida and Callard, 2001; Dalla Valle et al., 2002). These two distinct genes generate two 
structurally and functionally different aromatase proteins, CYP19A1 or P450 Aro A (AroA), 
and CYP19A2 or P450 Aro B (AroB) (Tchoudakova and Callard, 1998; Chiang et al., 2001a; 
Blazquez and Piferrer, 2004). These genes have distinct expression patterns : the brain 
aromatase activity is mainly due to the expression of the cyp19b gene while the ovarian 
aromatase activity is mainly due to the expression of the cyp19a gene (Tchoudakova and 
Callard, 1998; Chiang et al., 2001b; Forlano et al., 2001; Kishida and Callard, 2001; Trant et 
al., 2001; Dalla Valle et al., 2002; Menuet et al., 2005).  
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In teleost fish, brain aromatase activity is much higher than in mammals (Pasmanik 
and Callard, 1985; Pasmanik and Callard, 1988). This very high expression of brain 
aromatase could be linked to the capability of fish brain to grow during adulthood (Gelinas et 
al., 1998; Forlano et al., 2001). In the gonads, transcription of the aromatase gene has been 
proposed as a key step in the process of ovarian differentiation. For instance, in the rainbow 
trout (Oncorhynchus mykiss), inhibition of ovarian aromatase in undifferentiated female 
resulted in a complete masculinization of an all-female population (Guiguen et al., 1999). 
Moreover, during the female reproductive cycle, ovarian secretion of 17 -estradiol controls 
the hepatic synthesis of vitellogenin, a phospho-lipoprotein corresponding to the major 
precursor of embryonic trophics reserves (Flouriot et al., 1997).  
Recent studies have reported alterations of brain and/or ovarian P450 aromatase 
activities in wild fish collected from contaminated sites (Noaksson et al., 2001; Orlando et al., 
2002; Noaksson et al., 2003; Lavado et al., 2004) suggesting that fish populations are exposed 
to substances that perturb the biosynthesis of estrogens. However the nature (and the levels) 
of substances involved in these biological responses remains to be determined. In fish, a few 
studies have shown that environmental chemicals can interfere with aromatase activity. In 
these studies, the range of substances was limited to some pesticides (Monod et al., 1993, 
Noakson et al., 2003, Ankley et al., 2005 ) and polycyclic aromatic hydrocarbons (PAHs) 
(Monteiro et al., 2000). Thus, there is a need to provide a broader, more systematic 
knowledge on aromatase inhibiting potencies of environmental chemicals. Further, most of 
the available studies have analysed only gonadal aromatase and it remains to be determined 
whether the brain form is likewise affected. 
Considering the critical role of aromatase in development and reproduction in fish as 
well as the large number of chemical substances that can potentially affect this enzyme, the 
aim of this study was to investigate whether several substances belonging to diverse chemical 
classes (pesticides, polycyclic aromatic hydrocarbon, heavy metals) affect brain and ovarian 
aromatase activities in rainbow trout (Oncorhynchus mykiss) in vitro. For this purpose, we 
first optimized a microsomal aromatase assay to measure the effect of xenobiotics on 
aromatase activity in fish. 
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MATERIALS AND METHODS 
 
Reagents and chemicals 
 
[1β-3H (N)]androst-4-ene-3,17-dione (specific activity 25.3 Ci / mmol) was purchased from 
Perkin Elmer (France). Glucose-6-phosphate dehydrogenase was obtained from Fluka 
(France). -NADPH tetrasodium salt, -NADP sodium salt, glucose-6-phosphate dipotassium 
salt were purchased from Sigma-Aldrich (France). Diuron, heavy metals (triphenylarsine, 
cadmium chloride, and methyl mercury), PAHs (Benzo-[a]-pyrene (B[a]P) and chrysene), 
pentachlorophenol, 4-hydroxyandrostenedione, aminoglutethimide and clotrimazole were 
purchased from Sigma-Aldrich (France). Aldrin, alpha-cypermethrin, amitrol, atrazine, 
benomyl, bupirimate, chlordane, difenoconazole, endosulfan, fenarimol, fenbuconazole, 
fipronil, heptachlor, imazalil, iprodion, isoproturon, mecoprop, methoxychlor, metolachlor, 
parathion-methyl, permethrin, prochloraz, propiconazole, simazine, triadimenol, trifluralin, 
and vinclozolin comes from Riedel-de-Haën (France). Tri-n-butyltin chloride (TBT) was 
obtained from Acros Organics (France). 2,3,7,8 TCDD was obtained from Promochem 
(France), lead acetate was obtained from Rectapur (France) and 1,4,6-androstatrien-3,17-
dione was obtained from Steraloïds (USA). Azimsulfuron comes from Du Pont (France), and 
oxadiazon from Supelco (France). Reagents and chemicals were of the highest purity.  
 
Origin of fish, fish maintenance and dissections 
 
Female rainbow trout (Oncorhynchus mykiss) were obtained from two experimental fish 
farms (INRA, Gournay-sur-Aronde, France and INRA, Jouy-en-Josas, France). The fish were 
maintained in the laboratory under a natural photoperiod in 500 litres tanks supplied with 
dechlorinated tap water (temperature 15.5 +/- 1.3°C, pH 8.06 +/- 0.18, dissolved oxygen 8.80 
+/- 0.18 mg/l, conductivity 667.0 +/- 6.5 µS/cm), and were fed twice a week with granules 
NEO prima 5 (Le gouessant aquaculture, France). Fish were killed by cranial blow, then 
measured and weighed. The brain and the ovaries were removed and the gonads weighed to 
determine the gonado-somatic index (GSI). After removal, tissues were rinsed in ice cold KCl 
(0.15 M). In order to obtain sufficient material for preparation of brain and gonad 
microsomes, brains or ovaries of fish were pooled according to their GSI and different batches 
of brain and ovarian microsomes were constituted such as follows : for each tissue, 4 batches 
of microsomes were obtained from females having GSI < 1% (“low GSI”, N = 12 fish / 
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batch), 2 other batches were obtained from females having GSI comprised between 8 % and 
13 % (“medium GSI”, N = 13 fish / batch) and 2 batches were obtained from females having 
GSI > 13 % (“high GSI”, N = 17 fish / batch).  
 
Preparation of brain and ovarian microsomes  
 
Pooled brain or gonad tissues were homogenized with a Teflon potter homogenizer  in a 50 
mM potassium phosphate buffer, pH 7.4, containing 1 mM PMSF, 1 mM EDTA and 20 % 
glycerol (v/v) in a ratio of 1:2 (w:v). After centrifugation of the homogenates (10,000 g, 20 
min, 4°C), the supernatants were collected and centrifuged at 100,000 g (90 min, 4°C). The 
microsomal pellet was then resuspended in the same buffer as used for the homogenisation 
(100 µl / fish) and the total amount of microsomal protein determined (Bradford, 1976) using 
BSA (Bovine Serum Albumin, Sigma-Aldrich, France) as standard. Microsomes were then 
aliquoted and stored at –80°C until used. 
 
Measurement of brain and ovarian aromatase activities 
 
Aromatase activity was determined by the tritiated water assay which measures the release of 
tritiated water during the conversion of [1β-3H (N)]androst-4-ene-3,17-dione to estrone 
(Thompson and Siiteri, 1974). Optimal concentrations of brain and gonads microsomal 
proteins were determined as well as concentration of substrate, the duration and the 
temperature at which the enzymatic reaction occurred. The resulting assay protocol is 
described below. For the aromatase assay, 200 µg of brain or ovarian microsomal proteins 
were added to a potassium phosphate buffer (50 mM) containing a NADPH-generating 
system and consisting of 20 µM β-NADPH, 1 mM β-NADP, 10 mM glucose-6-phosphate, 
and 2 U/ml glucose-6-phosphate dehydrogenase. To assess the effect of test compounds on 
aromatase activity, substances were dissolved in either dimethylsulfoxide (DMSO) or ethanol 
Solvent concentration did not exceed 0.2 % of the final reaction mixture, i.e. 500 µl. Test 
compounds were incubated with microsomes during 1 hour at 27°C. The rationale for 
choosing 1 hour of incubation was to increase sensitivity of the aromatase assay. Indeed in a 
preliminary experiment, we showed that brain and ovarian IC50 (defined as the concentration 
of chemical required for 50% inhibition of aromatase activity) calculated for 4-
hydroxyandrostenedione were respectively 1.8 and 4.5 times lower for one hour of incubation 
compared to ten minutes (data not shown). After one hour at 27°C, the reaction was started by 
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addition of 75 nM of [1β-3H (N)]androst-4-ene-3,17-dione. Appropriate controls without 
substrate (tissue control), cofactors, and substitution of microsomal proteins for BSA, and 
addition of the specific aromatase inhibitor 4-hydroxyandrostenedione at a concentration of 
0.5 µM were used. After 30 min at 27°C, the reaction was stopped by the addition of 1 ml of 
chloroform. After extensive vortexing for 30 sec, the tubes were centrifuged at 3000 g (10 
min, 4°C). The aqueous layer was removed and extracted again with 1 ml of chloroform. The 
aqueous layer was mixed with charcoal (5 %, w/v) to eliminate remaining organic 
compounds, vortexed for 30 sec and centrifuged at 4000 g (20 min, 4°C). Then two aliquots 
of the supernatant (2 150 µl) were mixed with 750 µl of scintillation liquid (OptiPhase ‘Hi 
safe’ 3, Perkin Elmer, France) in two different wells of a 24-well plate (Flexibles plates 24-w, 
Perkin Elmer, France) and counted for 2 min in a Liquid Scintillation Counter (Microbeta, 
Perkin Elmer, France). As a first screening step all xenobiotics were tested at 10 µM. For IC50 
determination, all compounds were tested at concentrations between 10 nM and 100 µM 
except aminoglutethimide for which one concentration was added (250 µM) and 
androstatrienedione and 4-hydroxyandrostenedione which were tested between 0.01 nM and 1 
µM. 
 
Data analysis and statistics 
 
The enzyme kinetic parameter (Vmax and Km) were calculated from Lineweaver-Burk 
inverse plots. The aromatase inhibition potency of the tested substances was expressed as IC50 
calculated using the Regtox macro for Microsoft Excel freely available at 
http://eric.vindimian.9online.fr/download.html REGTOX_EV7.0.5.xls (Vindimian et al., 
1983). Data were also expressed by the relative potency of aromatase inhibition (RPAI) 
calculated as the ratio of IC50 value of 4-hydroxyandrostenedione to test compound. 
Experimental data were expressed as mean ± standard deviation (N = 3 independent 
experiments performed in ducplicate). The SPSS™ software version 10.1 for Windows 




Establishment and optimisation of the microsomal aromatase assay 
 
Subcellular localisation of the aromatase activity and specificity of the aromatase assay  
 
Aromatase activity was measured in the microsomal and cytosolic fraction of brain and 
gonads. In both brain and ovaries, the highest aromatase activity was located in the 
microsomal fraction (> 90 % in the microsomes and < 10 % in the cytosol, data not shown), 
which is in agreement with the subcellular localisation of the aromatase enzyme, i.e. the 
endoplasmic reticulum (Simpson et al., 1994). In controls (without substrate or cofactor, 
substitution of microsomes for BSA or with 4 hydroxyandrostenedione), no aromatase 
activity was found (data not shown). All together, these experiments showed that the method 
is specific of the aromatization reaction.  
 
Effect of amount of microsomal protein and time of incubation on microsomal aromatase 
activity 
 
In the tritiated water assay, quantification of aromatase activity depends on degree of linearity 
of the reaction with respect to time and amount of total protein. At all concentrations of 
microsomal proteins tested (0.1, 0.2 and 0.5 mg), aromatase activities in brain and ovaries 
were linear for up to 30 minutes (Fig. 1). Accordingly, brain and ovarian aromatase activities 
measured after 30 min were proportional to the amount of microsomal proteins in the assay 
(data not shown). Based on these results, 200 µg of microsomal proteins and 30 min of 
incubation time were chosen as standard procedure for the subsequent measurements on brain 
and ovarian aromatase activities.  
 
Effect of substrate concentration on brain and ovarian microsomal aromatase activities : 
determination of affinity for androstenedione (Km) and maximum reaction rates (Vmax) 
 
In order to ensure saturating concentration of substrate available for the enzyme, the effect of 
substrate concentration on brain and ovarian aromatase activities was assessed. In brain and 
ovarian microsomes, aromatase activity was maximal at 75 nM of radiolabelled 
androstenedione and above (Fig 2A, B). This concentration was chosen to ensure that the 
substrate was not limiting.  
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By using the established aromatase assay, the rainbow trout aromatase affinity for 
androstenedione (Km) and its maximum reaction rate (Vmax) were determined in both brain 
and ovarian microsomes (Fig 2A, B). The Km values for androstenedione in brain and ovary 
were 9.9 +/- 2.6 nM and 7.48 +/- 1.14 respectively without significant difference. In contrast, 
Vmax were much higher in brain (Vmax = 453.7 +/- 24.5) than in ovary (51.0 +/- 1.5 
fmol/mg/min) (Fig 2A, B).  
 
Effect of incubation temperature of microsomes on aromatase activity 
 
Variations of the incubation temperature resulted in significant changes in aromatase activity 
(Fig. 3A, B). In brain and in ovarian microsomes, aromatase activity was maximal at 18°C 
and 27°C respectively. At 37°C, aromatase activities in both brain and gonad were completely 
inhibited. In order to verify that temperature did not influence the effects of xenobiotics in the 
aromatase assay, microsomes were exposed to known aromatase inhibitors and incubated at 
18 or 27°C. As shown by the Figure 4, the calculated brain and ovarian IC50 for 4-
hydroxyandrostenedione and prochloraz were the same at both temperatures. Based on this 
data, the incubation temperature used for the microsomal assay was set at 27°C.  
 
Brain and ovarian aromatase activities measured in the different batches of microsomes 
 
Whatever the batch of microsomes, brain aromatase activity was systematically higher than  
ovarian activity (Table I). Moreover, brain and ovarian aromatase activities were significantly 
different among batches : in microsomes isolated from the “high GSI” group, brain aromatase 
activity was significantly higher than in microsomes isolated from fish of the “low” and 
“medium” GSI groups. In contrast, no aromatase activity was measured in ovarian 
microsomes isolated from females of the “high GSI” group. From a practical point of view, 
the effect of environmental pollutants on brain and ovarian aromatase activities was tested on 
microsomes of the “medium GSI group”, where both brain and ovarian aromatase activities 
were high.  
 
Effect of environmental pollutants on brain and ovarian aromatase activities  
 
Forty three environmental chemicals from different chemical classes were tested for their 
ability to interfere with brain and ovarian aromatase activities. As a first screening step, 
experiments were conducted by testing all the compounds at 10µM except for few of them 
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which where tested at lower concentrations due to solubility limitations. The results from 
these experiments are summarized in Table II. Twelve out of 43 substances were potent 
inhibitors of aromatase activity in vitro at 10 µM both in the brain and ovaries: 
androstatrienedione, 4-hydroxyandrostenedione, aminoglutethimide, clotrimazole, fenarimol, 
difenoconazole, fenbuconazole, imazalil, prochloraz, propiconazole, triadimenol, and 
methylmercury (Table II). None of the other tested chemicals exhibited any significant effect 
on aromatase activity at the concentrations tested. For the active substances, dose-response 
experiments were then conducted to determine their IC50 values. The results are summarised 
in Table III. Steroidal compounds (4-hydroxyandrostenedione and androstatrienedione) were 
found to be the most potent aromatase inhibitors with IC50 values in the low nM range. The 
non steroidal compound aminoglutethimide was found to be the least potent aromatase 
inhibitor among all the inhibiting substances tested in this study with a relative potency of 
aromatase inhibition (RPAI) for brain and ovary equal to 4.6 10-5 and 4.1 10-6 respectively 
compared to 4-hydroxyandrostenedione. In contrast, the imidazole fungicide clotrimazole 
inhibited the brain and ovarian aromatase activities with a potency of inhibition in brain close 
to that of 4-hydroxyandrostenedione (RPAIbrain = 0.8 and RPAIovary = 0.009). With the 
exception of methylmercury, all the aromatase inhibiting xenobiotics were fungicides 
belonging to the triazole, imidazole and pyrimidine families and were characterized by IC50 
values ranging from the low to the high µM range (Table III). Linear regression analysis 
showed that there exists a significant and positive correlation between the inhibitory action of 
a substance on the ovarian aromatase and on the brain aromatase (R2 = 0.85; Pearson’s test, 
p< 0.01, Fig. 5). Interestingly, despite this overall correlation, tissue specific effects were 
highlighted for certain chemicals. For the four fungicides (clotrimazole, imazalil, prochloraz 
and propiconazole), no significant differences of their brain and ovarian IC50 values were 
noted. In contrast, 4 out of 12 compounds (4-hydroxyandrostenedione, androstatrienedione, 
difenoconazole, and methylmercury) showed ovarian IC50 values significantly lower than 
those measured in the brain (student’s t test, p<0.05). IC50 of aminoglutethimide and 
fenbuconazole were also lower than brain IC50 but the difference was not statistically 
significant (Student’s –t test, p = 0.06 and 0.07 respectively). Finally, triadimenol had 
stronger inhibitory effect on the brain than on the ovarian aromatase activity (Student’s t test, 
p<0.05). Fenarimol had the same pattern of inhibitory effect as triadimenol but the difference 




This paper describes the potential endocrine disrupting activity of xenobiotics by 
assessing their capacities to inhibit in vitro brain and ovarian aromatase activities of rainbow 
trout. We first optimized the tritiated water assay, characterized aromatase activity in the two 
target tissues and determined the kinetic parameters of the aromatase in brain and ovarian 
microsomes. Then we showed that several environmental substances are able to inhibit both 
brain and ovarian aromatase activities in a dose-dependent manner, indicating that they can 
potentially interfere with biosynthesis of endogenous estrogens and alter the androgen : 
estrogen ratio. Among them, methylmercury and the triazole fungicide fenbuconazole were 
newly identified as in vitro inhibitors of aromatase activity in a vertebrate model.  
 
Rainbow trout brain and ovarian microsomal aromatase assay  
 
The tritiated water assay to measure aromatase activity has been already applied to 
several fish species, including goldfish (Carassius auratus) (Pasmanik and Callard, 1985), 
medaka (Oryzias latipes) (Melo and Ramsdell, 2001), perch (Perca fluviatilis) and roach 
(Rutilus rutilus) (Noaksson et al., 2001), sea bass (Dicentrarchus labrax) (Gonzalez and 
Piferrer, 2002; Gonzalez and Piferrer, 2003) and rainbow trout (Oncorhynchus mykiss) 
(Monod et al., 1993; Shilling et al., 1999). We aimed to optimize the assay in such a way that 
it fits to both ovarian and brain aromatase activities, and to determine whether brain and 
ovarian aromatase differ in their key kinetic parameters, Vmax and Km. Amount of protein, 
length of incubation time, and substrate concentration were found to influence aromatase 
activity, a finding which is in accordance with the observations of Gonzalez and Piferrer 
(2002) on aromatase activity in sea bass. Also temperature influenced aromatase activity. The 
temperature effect on aromatase activity can be associated with decreasing cyp19 mRNA 
expression in tilapia with increasing water temperature (D'Cotta et al., 2001; Tsai et al., 
2003). Aromatase activity of rainbow trout showed lower temperature maxima than aromatase 
activity of sea bass (30°C and 40°C for brain and ovary, respectively, in sea bass (Gonzalez 
and Piferrer, 2002)), a difference that might be related to the fact that rainbow trout is a cold 
water teleost fish species while sea bass live at higher temperatures.  
 
Comparison of the catalytic properties  
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To our knowledge, this study is the first to report Vmax and Km values for both the 
brain and ovarian P450 aromatase in rainbow trout. The Vmax value of the brain aromatase is 
nine-fold higher than that of ovarian aromatase (453.72  24.50 and 51.04  1.52 
fmol/mg/min respectively). These results are in accordance with the ten-fold higher Vmax of 
goldfish brain aromatase isoform compared to ovary isoform (Zhao et al., 2001) and are in 
line with the four-fold higher Vmax of sea bass brain aromatase compared to ovary (Gonzalez 
and Piferrer, 2002). Moreover, the Vmax calculated for the ovaries is similar to the Vmax 
reported by Shilling et al. (1999) for rainbow trout (71.1 fmol/mg/min). While brain exhibited 
higher catalytic activity compared to the ovary, brain and ovarian Km values were not 
significantly different, demonstrating similar and very high affinities of both aromatases for 
androstenedione. Our data are well in accordance with Km values reported in literature for 
other teleost fish species : 5 nM in goldfish brain homogenates (Pasmanik and Callard, 1988), 
8.2 nM in goldfish brain microsomes (Zhao et al., 2001), 4.1 and 3.4 nM in brain and ovarian 
sea bass microsomes respectively (Gonzalez and Piferrer, 2002). However, it should be noted 
that our ovarian Km value is in disagreement with that reported by Shilling et al. (1999) for 
rainbow trout who found a 40-fold higher value.  
 
Effect of test chemicals on rainbow trout brain and ovarian aromatase activities  
 
Aromatase activity inhibition by known aromatase inhibitors  
 
In this study three aromatase inhibitors were used, namely two steroidal inhibitors, 4-
hydroxyandrostenedione and androstatrienedione, and a non steroidal inhibitor, 
aminoglutethimide. Steroidal inhibitors are steroid analogues of androstenedione. They bind 
irreversibly to the active site of the enzyme while non steroidal inhibitor act reversibly on 
P450 aromatase by interacting with the heme prosthetic group of the enzyme (Brodie et al., 
1986; Yue and Brodie, 1997). The capacities of these pharmaceuticals to inhibit aromatase 
have been extensively studied in mammals notably within the context of estrogen-dependant 
cancer therapy (see Geisler and Lonning, 2005 for a review). By using different in vitro 
human systems (i.e., placental microsomes, human adrenocortical cells H295R, human 
choriocarcinoma-derived JEG3 cells), the human IC50 values reported for these molecules 
ranged from 0.0015 µM to 1.5 µM for 4-hydroxyandrostenedione and from 0.0146 µM to 55 
µM for aminoglutethimide (see Table III). Our results clearly show that these compounds act 
as aromatase inhibitors in rainbow trout as well. That rainbow trout aromatase activity 
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appears to be more susceptible than that of some mammalian species may reflect the high 
affinity of these compounds for fish aromatase (Zhao et al., 2001). The inhibitory potency of 
the non steroidal aromatase inhibitor, aminoglutethimide, on brain and gonad aromatase 
activities of trout was much less expressed than that of the steroidal substances. This gives 
support to previous findings on goldfish and rainbow trout aromatase (Shilling et al., 1999; 
Zhao et al., 2001). By calculating the RPAI of aminoglutethimide for human aromatase based 
on IC50 data reported in different studies (Yue and Brodie, 1997; Ohno et al., 2004), we found 
that aminoglutethimide was 10 to 1200-fold less effective in inhibiting rainbow trout than 
human aromatase. Similarly, letrozole, exhibited a 1000-fold less inhibitory potency in 
rainbow trout than in human (Shilling et al., 1999). A recent study reported 53 % overall 
identity of the deduced amino-acid sequence of brain trout aromatase with that of human 
(Dalla Valle et al., 2002). This may imply that  there exist differences of tertiary structure 
between human and trout P450 aromatase that could explain differences in efficacy and 
mechanism of inhibition (Pelissero et al., 1996; Shilling et al., 1999). The data of the present 
study show that there exist differences in the inhibitory potency of substances for trout and 
mammalian aromatase. Additionally, differences are evident between brain and gonad P450 
aromatase. This underlines that although some knowledge is available for the inhibitory action 
of chemicals on aromatase activity in mammals, this can not  be linearly extrapolated to 
teleostean aromatase activity.  
We found that the efficacy of inhibition of ovarian aromatase by aminoglutethimide 
and the two steroidal inhibitors were 5 and 60 fold higher respectively comparatively to brain. 
In the study of Zhao et al. (2001) it has been demonstrated that steroidal inhibitor have higher 
affinity for ovarian aromatase isozyme than brain aromatase in goldfish by determining the 
Ki. Given that rainbow trout aromatase activities in brain and ovary are supported by two 
structurally different proteins, i.e. P450AroA in ovary and P450AroB in brain (Dalla Valle et 
al., 2002), it is possible that the differences in the amino-acid sequences of rainbow trout 
aromatase isozymes account for distinct response to aromatase inhibitors (IC50 values) as 
previously suggested for goldfish aromatases (Zhao et al., 2001).  
 
Aromatase Inhibition by environmental substances 
 
Among the environmental substances tested in this study, nine inhibited brain and 
ovarian aromatase activities in a dose-dependent manner among which were seven triazole 
and imidazole fungicides. Due to their well described capacity to inhibit sterol 14- -
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demethylase which catalyses the synthesis of ergosterol, an essential membrane component in 
yeast and fungi, azole fungicides are widely used as antimycotic agents in agriculture and in 
human and veterinary therapies (Zarn et al., 2003). Various imidazole-like compounds have 
been shown to inhibit aromatase in human placenta microsomes, and in different cell lines 
expressing aromatase (Mason et al., 1987; Ayub and Levell, 1990; Vinggaard et al., 2000; 
Andersen et al., 2002; Sanderson et al., 2002; Ohno et al., 2004). In fish, data are more 
scarce. Previous studies reported that some imidazole fungicides (clotrimazole, prochloraz, 
imazalil) are able to inhibit aromatase activity in fish (Monod et al., 1993; Noaksson et al., 
2003; Ankley et al., 2005). Our results confirm the capability of these imidazole fungicides to 
inhibit ovarian and also brain aromatase activities and extend the findings to other imidazole-
like compounds. We found that clotrimazole was the most potent aromatase inhibitor of in 
vitro aromatase activity, both in brain and ovary, among all the tested imidazole-like 
compounds. This is similar to the results of Monod et al. (1993) who found that this substance 
was a much more potent ovarian aromatase inhibitor than prochloraz and imazalil (see Table 
III). In a cyprinid fish species, the roach (Rutilus rutilus), clotrimazole has also been shown to 
inhibit in vitro brain aromatase activity with an IC50 of 0.9 µM (Noaksson et al., 2003). Brain 
and ovarian IC50 values obtained in the present study for clotrimazole were lower than those 
observed previously (Monod et al., 1993; Noaksson et al., 2003) which is probably due to the 
use of optimized assay conditions and the resulting enhanced sensitivity of the assay. Besides, 
species difference cannot be ruled out since the highest IC50 value for clotrimazole was 
reported for the roach. This hypothesis is further supported by the very low degree of 
inhibition of aromatase by fenarimol in the fathead minnow compared to rainbow trout 
(Ankley et al., 2005). Nevertheless, IC50 values for prochloraz reported for the fathead 
minnow by Ankley et al. (2005) are similar to those reported in trout (Monod et al., 1993). 
Whether there exists species difference in sensitivity of aromatase remains to be determined.  
Among the imidazole-like compounds tested in this study, only benomyl and amitrol 
had no effect on aromatase activity. The absence of an inhibitory effect of these two 
molecules is likely due to their chemical structures. Although relationship between the 
structure and the biological activity as inhibitors of aromatase is not simple (Sanderson et al., 
2002), it has been shown that both molecules containing an imidazole ring fused to a benzene 
ring (e.g. benomyl) and molecules containing an imidazole ring without aromatic ring on the 
N-1 substituent (e.g. amitrol) are very weak inhibitors of human aromatase (Ayub and Levell, 
1988). Therefore, our results strongly suggest that this type of structure activity described for 
human aromatase is also true for rainbow trout brain and ovarian aromatase.  
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Among the other substances tested, only methylmercury inhibited brain and ovarian 
aromatase activities in a dose-dependent manner. The ability of this substance to inhibit 
vertebrate aromatase has not been described before and the mechanism of inhibition remains 
to be determined. Molecules such as TBT, lead, TCDD, B[a]P, chrysene, atrazine, simazine, 
or vinclozoline are known to perturb aromatase expression in vitro in different cell systems 
(Letcher et al., 1999; Monteiro et al., 2000; Saitoh et al., 2001; Sanderson et al., 2001; 
Sanderson et al., 2002; Taupeau et al., 2003) but failed to produce any effect in our cell-free 
system. These differences rely most probably on the mechanism of action of these substances 
which are able of up- or down regulating the aromatase gene transcription (Saitoh et al., 2001; 
Sanderson et al., 2001; Sanderson et al., 2002; Taupeau et al., 2003).  
The in vitro microsomal aromatase assay is limited to measuring the inhibitory 
effects of the test compound on aromatase enzymatic activity through direct interaction with 
the enzymatic complex but does not provide any information on the effect of the test agent on 
the gene / protein machinery. Nonetheless, the aromatase assay can be used for 
ecotoxicological screening in order to identifying and characterising the mode of action and 
endocrine effects of environmental contaminants on a key steroidogenic enzyme. Since brain 
and ovarian Log IC50 values were significantly and positively correlated (Fig 5), 
environmental contaminants can be tested either on brain or ovarian microsomes. However, 
brain microsomes can be recommended since brain aromatase activities can be measured 
whatever the maturity of fish.  
Several of the aromatase inhibiting substances found in our study are known to be 
present in the aquatic environment and to accumulate in fish. Methylmercury is a well-known 
contaminant of the aquatic food web that may adversely affect reproduction of wild 
population of fish (Drevnick and SandHeinrich, 2003). In a recent survey of pharmaceuticals 
in aquatic environment, it has been shown that the fungicide clotrimazole was present at low 
concentrations (up to 33 ng/L) in some UK estuaries and rivers (Thomas and Hilton, 2004; 
Roberts and Thomas, 2006). In surface water of French rivers, difenoconazole, 
fenbuconazole, iprodion, prochloraz and propiconazole have been measured at mean 
concentrations in the low ng/L range with maximal concentration of 1.75 µg/L for 
propiconazole (IFEN, 2001). As a consequence, all these substances could potentially 
represent a risk for fish populations and may be involved in altered aromatase activity that 
have been observed in wild fish population inhabiting contaminated water (Noaksson et al., 
2001; Orlando et al., 2002; Noaksson et al., 2003; Lavado et al., 2004; Noaksson et al., 2004; 
Noaksson et al., 2005; Martin-Skilton et al., 2006). However, few studies have been 
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conducted to assess the in vivo effect of these compounds on brain and ovarian aromatase 
activities in fish and it would be advisable to determine to which extent the inhibitory potency 
of xenobiotics on in vitro aromatase activity can be extrapolated to the in vivo situation. Our 
results concerning the inhibitory effect of methylmercury on brain and ovarian aromatase 
activities are consistent with the decreasing circulating concentrations of estradiol measured 
in female fathead minnow fed with methylmercury (Drevnick and Sandheinrich, 2003). 
Similarly, prochloraz in the fathead minnow caused a suite of in vivo responses consistent 
with inhibition of steroidogenesis, i.e. decrease of estradiol and vitellogenin synthesis in 
female (Ankley et al., 2005). However, the same authors showed that the endocrine effects of 
fenarimol were more ambiguous with notably an increased concentration of circulating 
estradiol in female. Shilling et al. (1999) failed to demonstrate any effect on aromatase and 
vitellogenin synthesis in juvenile female rainbow trout exposed to clotrimazole. All these data 
suggest that extrapolation of in vitro study of xenobiotics interference with aromatase enzyme 
(and more generally steroidogenic enzyme) to the in vivo situation is not an easy task. It 
should be related to the in vivo pharmaco-toxicokinetic and the multiple mode of action of 
these molecules on the endocrine system as well as the complexity of the synthesis pathway 
(Andersen et al., 2002; Sanderson and Van den Berg, 2003; Ankley et al., 2005). Taken 




The optimized aromatase activity assay with rainbow trout microsomes developed in 
this study is a suitable test for screening for aromatase inhibiting activities of environmental 
contaminants. The assay can distinguish inhibitory effects in the brain and the ovary, and we 
show for the first time that the two tissues differ in their sensitivity to chemical inhibition. 
While ovary exhibited a higher sensitivity to steroidal inhibitors as compared to brain, the 
sensitivity of the two aromatases to environmental substances was broadly similar indicating 
that brain and ovarian aromatase are relevant biochemical target of EDCs. Our study also 
indicates that methylmercury and some pesticides (clotrimazole, imazalil, prochloraz, 
fenbuconazole, propiconazole, difenoconazole, triadimenol, and fenarimol), that are currently 
used throughout the world, have the potential to interfere with the biosynthesis of endogenous 
estrogens. Based on these results, it can be suggested that these compounds will affect the 
functioning of the HPG axis and in turn sexual development and reproduction of fish. 




This study was supported by the French Ministry of Ecology and Sustainable Development 
(Budget Civil de Recherche et Développement, BCRD Grant AP17-02). N. Hinfray is funded 
by INERIS and ARNT (National association for technical research). The authors would like 
to express their thanks to Dr Sélim Aït-Aissa (Unité d’évaluation des risques 
écotoxicologiques, INERIS), Professor Helmut Segner (University of Bern, Centre for Fish 
and Wildlife Health, Switzerland) and Professor Roger A. Coulombe (Utah State University, 
Department of veterinary sciences, USA) for their critical reading and comments of the 




Andersen, H.R., Vinggaard, A.M., Rasmussen, T.H., Gjermandsen, I.M., Bonefeld-Jorgensen, 
E.C., 2002. Effects of currently used pesticides in assays for estrogenicity, androgenicity, and 
aromatase activity in vitro. Toxicol. Appl. Pharmacol., 179 (1), 1-12. 
 
Ankley, G.T., Jensen, K.M., Durhan, E.J., Makynen, E.A., Butterworth, B.C., Kahl, M.D., 
Villeneuve, D.L., Linnum, A., Gray, L.E., Cardon, M., Wilson, V.S., 2005. Effects of two 
fungicides with multiple modes of action on reproductive endocrine function in the fathead 
minnow (Pimephales promelas). Toxicol. Sci., 86 (2), 300-308. 
 
Ayub, M., Levell, M.J., 1988. Structure-activity relationships of the inhibition of human 
placental aromatase by imidazole drugs including ketoconazole. J. Steroid. Biochem., 31 (1), 
65-72. 
 
Ayub, M., Levell, M.J., 1990. The inhibition of human prostatic aromatase activity by 
imidazole drugs including ketoconazole and 4-hydroxyandrostenedione. Biochem. 
Pharmacol., 40 (7), 1569-1575. 
 
Blazquez, M., Piferrer, F., 2004. Cloning, sequence analysis, tissue distribution, and sex-
specific expression of the neural form of P450 aromatase in juvenile sea bass (Dicentrarchus 
labrax). Mol. Cell. Endocrinol., 219 (1-2), 83-94. 
 
Bradford, M., 1976. A rapid and sensitive method for the quantitation of microgram quantities 
of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72 248-254. 
 
Brion, F., Tyler, C.R., Palazzi, X., Laillet, B., Porcher, J.M., Garric, J., Flammarion, P., 2004. 
Impacts of 17 -estradiol, including environmentally relevant concentrations, on reproduction 
after exposure during embryo-larval-, juvenile- and adult-life stages in zebrafish (Danio 
rerio). Aquat. Toxicol., 68 (3), 193-217. 
 
Brodie, A.M., Wing, L.Y., Goss, P., Dowsett, M., Coombes, R.C., 1986. Aromatase inhibitors 
and their potential clinical significance. J. Steroid Biochem., 25 (5B), 859-865. 
 
 19 
Callard, G.V., Tchoudakova, A., 1997. Evolutionary and functional significance of two 
CYP19 genes differentially expressed in brain and ovary of goldfish. J. Steroid Biochem. 
Mol. Biol., 61 (3-6), 387-392. 
 
Chiang, E.F., Yan, Y.L., Guiguen, Y., Postlethwait, J., Chung, B., 2001a. Two Cyp19 (P450 
aromatase) genes on duplicated zebrafish chromosomes are expressed in ovary or brain. Mol. 
Biol. Evol., 18 (4), 542-550. 
 
Chiang, E.F., Yan, Y.L., Tong, S.K., Hsiao, P.H., Guiguen, Y., Postlethwait, J., Chung, B.C., 
2001b. Characterization of duplicated zebrafish cyp19 genes. J. Exp. Zool., 290 (7), 709-714. 
 
Dalla Valle, L., Ramina, A., Vianello, S., Belvedere, P., Colombo, L., 2002. Cloning of two 
mRNA variants of brain aromatase cytochrome P450 in rainbow trout (Oncorhynchus mykiss 
Walbaum). J. Steroid Biochem. Mol. Biol., 82 (1), 19-32. 
 
D'Cotta, H., Fostier, A., Guiguen, Y., Govoroun, M., Baroiller, J.-F., 2001. Aromatase plays a 
key role during normal and temperature-induced sex differentiation of tilapia Oreochromis 
niloticus. Mol. Reprod. Dev., 59 (3), 265-276. 
 
Drevnick, P.E., Sandheinrich, M.B., 2003. Effects of dietary methylmercury on reproductive 
endocrinology of fathead minnows. Environ. Sci. Technol., 37 (19), 4390-4396. 
 
Flouriot, G., Pakdel, F., Ducouret, B., Ledrean, Y., Valotaire, Y., 1997. Differential regulation 
of two genes implicated in fish reproduction: vitellogenin and estrogen receptor genes. Mol. 
Reprod. Dev., 48 (3), 317-323. 
 
Forlano, P.M., Deitcher, D.L., Myers, D.A., Bass, A.H., 2001. Anatomical distribution and 
cellular basis for high levels of aromatase activity in the brain of teleost fish: aromatase 
enzyme and mRNA expression identify glia as source. J. Neurosci., 21 (22), 8943-8955. 
 
France, J. T., Mason, J. I., Magness, R. R., Murry, B. A., Rosenfeld, C. R., 1987. Ovine 
placental aromatase: Studies of activity levels, kinetic characteristics and effects of aromatase 
inhibitors. J. Steroid Biochem., 28, 155–160. 
 
 20 
Geelen, J.A., Deckers, G.H., van der Wardt, J.T., Loozen, H.J., Tax, L.J., Kloosterboer, H.J., 
1991. Selection of 19-(ethyldithio)-androst-4-ene-3,17-dione (ORG 30958): a potent 
aromatase inhibitor in vivo. J. Steroid Biochem. Mol. Biol., 38 (2), 181-188. 
 
Geisler, J., Lonning, P.E., 2005. Aromatase inhibition: translation into a successful 
therapeutic approach. Clin. Cancer Res., 11 (8), 2809-2821. 
 
Gelinas, D., Pitoc, G., Callard, G.V., 1998. Isolation of a goldfish brain cytochrome P450 
aromatase cDNA : mRNA expression during the seasonal cycle and after steroid treatment. 
Mol. Cell. Endocrinol., 138 (1-2), 81-93. 
 
Gonzalez, A., Piferrer, F., 2002. Characterization of aromatase activity in the sea bass: effects 
of temperature and different catalytic properties of brain and ovarian homogenates and 
microsomes. J. Exp. Zool., 293 (5), 500-510. 
 
Gonzalez, A., Piferrer, F., 2003. Aromatase activity in the European sea bass (Dicentrarchus 
labrax L.) brain. Distribution and changes in relation to age, sex, and the annual reproductive 
cycle. Gen. Comp. Endocrinol. , 132 (2), 223-230. 
 
Guiguen, Y., Baroiller, J.-F., Ricordel, M.-J., Iseki, K., McMeel, O.M., Martin, S.A.M., 
Fostier, A., 1999. Involvement of estrogens in the process of sex differentiation in two fish 
species: The rainbow trout (Oncorhynchus mykiss) and a tilapia (Oreochromis niloticus). Mol. 
Reprod. Dev., 54 (2), 154-162. 
 
Hirsch K. S., Weaver D. E., Black L. J., Falcone J. F., MacLusky N. J., 1987. Inhibition of 
central nervous system aromatase activity: A mechanism for fenarimol-induced infertility in 
the male rat. Toxicol. Appl. Pharmacol., 91, 235-245. 
 
Institut Français de l'Environnement (IFEN), 2001. Pesticides in water, Fifth annual report. 1-
67. 
 
Jobling, S., Beresford, N., Nolan, M., Rodgers-Gray, T., Brighty, G.C., Sumpter, J.P., Tyler, 
C.R., 2002. Altered sexual maturation and gamete production in wild roach (Rutilus rutilus) 
living in rivers that receive treated sewage effluents. Biol. Reprod., 66 (2), 272-281. 
 21 
 
Kishida, M., Callard, G.V., 2001. Distinct cytochrome P450 aromatase isoforms in zebrafish 
(Danio rerio) brain and ovary are differentially programmed and estrogen regulated during 
early development. Endocrinology, 142 (2), 740-750. 
 
Lavado, R., Thibaut, R., Raldua, D., Martin, R., Porte, C., 2004. First evidence of endocrine 
disruption in feral carp from the Ebro River. Toxicol. Appl. Pharmacol., 196 (2), 247-257. 
 
Le Bail, J.C., Champavier, Y., Chulia, A.J., Habrioux, G., 2000. Effects of phytoestrogens on 
aromatase, 3beta and 17beta-hydroxysteroid dehydrogenase activities and human breast 
cancer cells. Life Sci., 66 (14), 1281-1291. 
 
Letcher, R.J., van Holsteijn, I., Drenth, H.-J., Norstrom, R.J., Bergman, A., Safe, S., Pieters, 
R., van den Berg, M., 1999. Cytotoxicity and Aromatase (CYP19) Activity Modulation by 
Organochlorines in Human Placental JEG-3 and JAR Choriocarcinoma Cells. Toxicol. Appl. 
Pharmacol., 160 (1), 10-20. 
 
Martin-Skilton, R., Lavado, R., Thibaut, R., Minier, C., Porte, C., 2006. Evidence of 
endocrine alteration in the red mullet, Mullus barbatus from the NW Mediterranean. Environ. 
Pollut., 141 (1), 60-68. 
 
Mason, J.I., Carr, B.R., Murry, B.A., 1987. Imidazole antimycotics: selective inhibitors of 
steroid aromatization and progesterone hydroxylation. Steroids, 50 (1-3), 179-189. 
 
Melo, A.C., Ramsdell, J.S., 2001. Sexual dimorphism of brain aromatase activity in medaka: 
induction of a female phenotype by estradiol. Environ. Health Perspect., 109 (3), 257-264. 
 
Menuet A., Pellegrini E., Brion F., Gueguen M-M, Dujardin T, Anglade I, Marmignon M, 
Pakdel F, Kah O. (2005). Expression and estrogen-dependent regulation of the zebrafish brain 
aromatase gene. J. Comp. Neurol. 16;485(4):304-20. 
 
Mills, L.J., Chichester, C., 2005. Review of evidence: are endocrine-disrupting chemicals in 
the aquatic environment impacting fish populations? Sci. Total Environ., 343 (1-3), 1-34. 
 22 
 
Monod, G., De Mones, A., Fostier, A., 1993. Inhibition of ovarian microsomal aromatase and 
follicular estradiol suppression by imidazole fungicides in rainbow trout. Mar. Environ. Res., 
35 153-157. 
 
Monteiro, P.R.R., Reis-Henriques, M.A., Coimbra, J., 2000. Polycyclic aromatic 
hydrocarbons inhibit in vitro ovarian steroidogenesis in the flounder (Platichthys flesus L.). 
Aquat. Toxicol., 48 (4), 549-559. 
 
Nash, J.P., Kime, D.E., Van der Ven, L.T., Wester, P.W., Brion, F., Maack, G., Stahlschmidt-
Allner, P., Tyler, C.R., 2004. Long-term exposure to environmental concentrations of the 
pharmaceutical ethynylestradiol causes reproductive failure in fish. Environ. Health Perspect., 
112 (17), 1725-1733. 
 
Noaksson, E., Tjarnlund, U., Bosveld, A.T.C., Balk, L., 2001. Evidence for Endocrine 
Disruption in Perch (Perca fluviatilis) and Roach (Rutilus rutilus) in a Remote Swedish Lake 
in the Vicinity of a Public Refuse Dump. Toxicol. Appl. Pharmacol., 174 (2), 160-176. 
 
Noaksson, E., Linderoth, M., Bosveld, A.T., Norrgren, L., Zebuhr, Y., Balk, L., 2003. 
Endocrine disruption in brook trout (Salvelinus fontinalis) exposed to leachate from a public 
refuse dump. Sci. Total Environ., 305 (1-3), 87-103. 
 
Noaksson, E., Gustavsson, B., Linderoth, M., Zebuhr, Y., Broman, D., Balk, L., 2004. Gonad 
development and plasma steroid profiles by HRGC/HRMS during one reproductive cycle in 
reference and leachate-exposed female perch (Perca fluviatilis). Toxicol. Appl. Pharmacol., 
195 (2), 247-261. 
 
Noaksson, E., Linderoth, M., Tjarnlund, U., Balk, L., 2005. Toxicological effects and 
reproductive impairments in female perch (Perca fluviatilis) exposed to leachate from 
Swedish refuse dumps. Aquat. Toxicol., 75 (2), 162-177. 
 
OECD (1997). Draft detailed review paper : appraisal of test methods for sex-hormone 
disrupting chemicals. Paris, OECD: 290. 
 
 23 
Ohno, K., Araki, N., Yanase, T., Nawata, H., Iida, M., 2004. A novel nonradioactive method 
for measuring aromatase activity using a human ovarian granulosa-like tumor cell line and an 
estrone ELISA. Toxicol. Sci., 82 (2), 443-450. 
 
Orlando, E.F., Davis, W.P., Guillette, L.J., Jr., 2002. Aromatase activity in the ovary and 
brain of the eastern mosquitofish (Gambusia holbrooki) exposed to paper mill effluent. 
Environ. Health Perspect., 110 Suppl 3 429-433. 
 
Pasmanik, M., Callard, G.V., 1985. Aromatase and 5 alpha-reductase in the teleost brain, 
spinal cord, and pituitary gland. Gen. Comp. Endocrinol. , 60 (2), 244-251. 
 
Pasmanik, M., Callard, G.V., 1988. Changes in brain aromatase and 5 alpha-reductase 
activities correlate significantly with seasonal reproductive cycles in goldfish (Carassius 
auratus). Endocrinology, 122 1349-1356. 
 
Pelissero, C., Lenczowski, M.J.P., Chinzi, D., Davail-Cuisset, B., Sumpter, J.P., Fostier, A., 
1996. Effects of flavonoids on aromatase activity, an in vitro study. J. Steroid Biochem. Mol. 
Biol., 57 (3-4), 215-223. 
 
Roberts, P.H., Thomas, K.V., 2006. The occurrence of selected pharmaceuticals in 
wastewater effluent and surface waters of the lower Tyne catchment. Sci. Total Environ., 356 
(1-3), 143-153. 
 
Saitoh, M., Yanase, T., Morinaga, H., Tanabe, M., Mu, Y.-M., Nishi, Y., Nomura, M., Okabe, 
T., Goto, K., Takayanagi, R., Nawata, H., 2001. Tributyltin or Triphenyltin Inhibits 
Aromatase Activity in the Human Granulosa-like Tumor Cell Line KGN*1. Biochem. 
Biophys. Res. Commun., 289 (1), 198-204. 
 
Sanderson, J.T., Letcher, R.J., Heneweer, M., Giesy, J.P., van den Berg, M., 2001. Effects of 
chloro-s-triazine herbicides and metabolites on aromatase activity in various human cell lines 




Sanderson, J.T., Boerma, J., Lansbergen, G.W.A., van den Berg, M., 2002. Induction and 
Inhibition of Aromatase (CYP19) Activity by Various Classes of Pesticides in H295R Human 
Adrenocortical Carcinoma Cells. Toxicol. Appl. Pharmacol., 182 (1), 44-54. 
 
Sanderson, T., van den Berg, M., 2003. Interactions of xenobiotics with the steroid hormone 
biosynthesis pathway. Pure Appl. Chem., 75 (11-12), 1957-1971. 
 
Segner, H., Caroll, K., Fenske, M., Janssen, C.R., Maack, G., Pascoe, D., Schafers, C., 
Vandenbergh, G.F., Watts, M., Wenzel, A., 2003. Identification of endocrine-disrupting 
effects in aquatic vertebrates and invertebrates: report from the European IDEA project. 
Ecotoxicol. Environ. Saf., 54 (3), 302-314. 
 
Shilling, A.D., Carlson, D.B., Williams, D.E., 1999. Rainbow trout, Oncorhynchus mykiss, as 
a model for aromatase inhibition. J. Steroid Biochem. Mol. Biol., 70 (1-3), 89-95. 
 
Simpson, E.R., Mahendroo, M.S., Means, G.D., Kilgore, M.W., Hinshelwood, M.M., 
Graham-Lorence, S., Amarneh, B., Ito, Y., Fisher, C.R., Michael, M.D., 1994. Aromatase 
cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr. Rev., 15 (3), 
342-355. 
 
Taupeau, C., Poupon, J., Treton, D., Brosse, A., Richard, Y., Machelon, V., 2003. Lead 
reduces messenger RNA and protein levels of cytochrome p450 aromatase and estrogen 
receptor beta in human ovarian granulosa cells. Biol. Reprod., 68 (6), 1982-1988. 
 
Tchoudakova, A., Callard, G.V., 1998. Identification of multiple CYP19 genes encoding 
different cytochrome P450 aromatase isozymes in brain and ovary. Endocrinology, 139 (4), 
2179-2189. 
 
Thomas, K.V., Hilton, M.J., 2004. The occurrence of selected human pharmaceutical 
compounds in UK estuaries. Mar. Pollut. Bull., 49 (5-6), 436-444. 
 
Thompson, E.A., Jr.,Siiteri, P.K., 1974. Utilization of oxygen and reduced nicotinamide 
adenine dinucleotide phosphate by human placental microsomes during aromatization of 
androstenedione. J. Biol. Chem., 249 (17), 5364-5372. 
 25 
 
Trant, J.M., Gavasso, S., Ackers, J., Chung, B.C., Place, A.R., 2001. Developmental 
expression of cytochrome P450 aromatase genes (CYP19a and CYP19b) in zebrafish fry 
(Danio rerio). J. Exp. Zool., 290 (5), 475-483. 
 
Trosken, E.R., Scholz, K., Lutz, R.W., Volkel, W., Zarn, J.A., Lutz, W.K., 2004. Comparative 
assessment of the inhibition of recombinant human CYP19 (aromatase) by azoles used in 
agriculture and as drugs for humans. Endocr. Res., 30 (3), 387-394. 
 
Tsai, C.L., Chang, S.L., Wang, L.H., Chao, T.Y., 2003. Temperature influences the 
ontogenetic expression of aromatase and oestrogen receptor mRNA in the developing tilapia 
(Oreochromis mossambicus) brain. J. Neuroendocrinol., 15 (1), 97-102. 
 
Vindimian, E., Robaut, C., Fillion, G., 1983. A method for cooperative or noncooperative 
binding studies using nonlinear regression analysis on a microcomputer. J. Appl. Biochem., 5 
(4-5), 261-268. 
 
Vinggaard, A.M., Hnida, C., Breinholt, V., Larsen, J.C., 2000. Screening of selected 
pesticides for inhibition of CYP19 aromatase activity in vitro. Toxicol. in Vitro, 14 (3), 227-
234. 
 
Yue, W., Brodie, A.M.H., 1997. Mechanisms of the actions of aromatase inhibitors 4-
hydroxyandrostenedione, fadrozole, and aminoglutethimide on aromatase in JEG-3 cell 
culture. J. Steroid Biochem. Mol. Biol., 63 (4-6), 317-328. 
 
Zarn, J.A., Bruschweiler, B.J., Schlatter, J.R., 2003. Azole fungicides affect mammalian 
steroidogenesis by inhibiting sterol 14 alpha-demethylase and aromatase. Environ. Health 
Perspect., 111 (3), 255-261. 
 
Zhao, J., Mak, P., Tchoudakova, A., Callard, G., Chen, S., 2001. Different catalytic properties 
and inhibitor responses of the Goldfish brain and ovary aromatase isozymes. Gen. Comp. 




Table I : Aromatase activity (AA) measured in the different batches of microsomes isolated 
from brain or ovary of females rainbow trout having different GSI. The number of batch / 
group of GSI is detailed in the Materials and Methods. n = number of independent measures 
performed on different batches of brain or ovarian microsomes. Different letters indicate 
statistically different values (Kruskall-Wallis test, and Mann-Whitney U test, p < 0.05). BDL 
= Below Detection Limit. 
 
GSI AA in brain microsomes 
(fmol/mg/min) 
AA in ovarian microsomes 
(fmol/mg/min) 
Low GSI 
< 1 % 
153.9 ± 59.3  a,d 
n = 16 
43.8 ± 6.0  c 
n = 27 
Medium GSI 
8 % - 13 % 
146.8 ± 5.1  a 
n = 13 
107.7 ± 27.6  d 
n = 11 
High GSI 
> 13 % 
428.9 ± 46.5  b 





Table II : Effect of environmental pollutants on aromatase activity (AA) in microsomes 
prepared from brain and ovary of rainbow trout. All chemicals were tested at 10 µM except 
4OHA (4-hydroxyandrostenedione), ATD (androstatrienedione), aldrin, heptachlor, and 
TCDD. The other concentrations are indicated in the table. Values are means of triplicates ± 
standard deviation. * indicate a significant difference compared to control (Student’s t test, p 
< 0.05). 
 
CHEMICALS FAMILY CHEMICALS % OF CONTROL AA (BRAIN) % OF CONTROL AA (OVARY)
Control 100.0 ± 8.4 100 ± 10.3
STEROIDAL INHIBITOR 4OHA (1µM) 2.7 ± 0.4 * 3.1 ± 3.1 *
ATD (1µM) 3.9 ± 0.9 * 2.1 ± 0.2 *
NON STEROIDAL INHIBITOR Aminoglutethimide 84.7 ± 2.8 * 70.7 ± 1.3 *
HEAVY METALS Cadmium chloride 106.1 ± 8.6 98.6 ± 10.3
Lead acetate 101.8 ± 7.8 99.2 ± 12.0
Methyl mercury 75.9 ± 2.1 * 15.7 ± 26.7 *
Triphanylarsine 107.8 ± 3.7 86.4 ± 1.5
H3AsO4 100.1 ± 2.6 100.0 ± 4.4
PAH Benzo[a]Pyrene 98.3 ± 2.0 102.9 ± 0.9
Chrysene 99.7 ± 1.1 105.2 ± 4.7
INSECTICIDES
organochlorine Aldrin (100nM) 92.5 ± 2.2 89.9 ± 4.7
Chlordane 105.5 ± 10.5 110.0 ± 9.5
Endosulfan 111.7 ± 0.3 107.6 ± 0.4
Heptachlor (100nM) 89.7 ± 8.8 89.7 ± 11.7
Methoxychlor 113.5 ± 2.3 84.5 ± 1.6
pyrazole Fipronil 107.2 ± 1.4 101.7 ± 19.4
pyrethroids Alpha-cypermethrin 83.7 ± 5.9 100.2 ± 5.0
Permethrin 87.3 ± 8.4 94.1 ± 4.9
FUNGICIDES
benzimidazol Benomyl 116.7 ± 0.4 102.3 ± 0.6
triazole Difenoconazole 81.7 ± 2.7 * 75.9 ± 2.9 *
Fenbuconazole 7.1 ± 0.9 * 6.7 ± 3.2 *
Propiconazole 10.1 ± 0.6 * 5.9 ± 0.5 *
Triadimenol 53.2 ± 1.5 * 69.8 ± 0.7 *
imidazole Clotrimazole 3.6 ± 0.1 * 0.0 ± 0.7 *
Imazalil 3.8 ± 0.5 * 2.6 ± 0.2 *
Prochloraz 18.0 ± 0.1 * 10.8 ± 0.4 *
dicarboximide Iprodion 115.1 ± 13.4 102.3 ± 4.9
Vinclozoline 100.5 ± 14.7 111.1 ± 11.7
pyrimidine Bupirimate 102.2 ± 8.9 92.2 ± 5.3
Fenarimol 46.4 ± 1.1 * 56.9 ± 0.8 *
HERBICIDES
Oxadiazon 87.5 ± 5.1 81.4 ± 5.7
chloroacetanilide Metolachlor 106.0 ± 4.5 109.6 ± 1.1
chlorotriazine Atrazine 114.7 ± 4.2 104.7 ± 3.2
Simazine 98.0 ± 14.1 108.7 ± 8.8
dinitroaniline Trifluralin 103.9 ± 12.6 102.1 ± 4.7
phenoxypropionic Mecoprop 105.8 ± 3.3 99.7 ± 5.4
phenylurea Diuron 97.7 ± 3.9 85.2 ± 4.5
Isoproturon 93.9 ± 8.1 89.9 ± 1.9
pyrimidinylsulfonylurea Azimsulfuron 112.9 ± 3.7 95.3 ± 18.7
triazole Amitrol 101.0 ± 0.9 93.8 ± 5.2
OTHERS Pentachlorophenol 109.8 ± 9.6 98.3 ± 1.6
TCDD (10-9 M) 112.0 ± 2.6 101.3 ± 3.1
TCDD (10-8 M) 116.7 ± 6.0 89.6 ± 2.6
Tributyltin chloride 91.4 ± 1.9 86.6 ± 0.1
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Table III : Comparative inhibition of aromatase activities in brain and ovarian microsomes in rainbow trout. The relative inhibition potency was 
calculated in comparison with 4-hydroxyandrostenedione. Dose-response experiments were conducted three times for each compound tested. 
Published IC50 values of the studied pesticides for placental assay, cells based assays and rainbow trout ovarian assay are also reported.  
 










IC50 in cells  
based assays 
(µM) 
IC50 in rainbow 
trout ovarian assay 
(µM) 
4-OH androstenedione 0.009 ± 0.001  0.00015 ± 0.00003  60.0 1 1 0.04 (a)- 1.4 (b) 0.0011 (c) - 0.08 (d) #1.5 (e)  
Androstatrienedione 0.015 ± 0.003  0.00025 ± 0.00018  60.0 0.6 0.6 - - ##0.5 (f)  
Aminoglutethimide 197 ± 54 36.8 ± 12.0 5.4 4.6E-05 4.1E-06 1 (g)-130 (f)  2.25 (c) -15.8 (d) 39 (f) , Ki = 2.4 (h) 
Clotrimazole 0.011 ± 0.004  0.016 ± 0.001 0.7 0.8 0.009 0.43 (i) - 1.8  (j)  0.05 (k) , 0.9  (l) 
Imazalil 0.43 ± 0.03  0.32 ± 0.21  1.3 2.1E-02 4.7E-04 0.04 (m) - 0.15 (j) 0.0044 (c)-0.1 (n) 5 (k) 
Prochloraz 1.3 ± 0.4 1.0 ± 0.5 1.3 6.9E-03 1.5E-04 0.34 (m)  - 0.70 (j) 0.1 (n) 5 (k), (11-7.2)**(o)  
Fenbuconazole 1.3 ± 0.4  0.21 ± 0.05  6.2 6.9E-03 7.1E-04 - - - 
Propiconazole 0.9 ± 0.3  0.9 ± 0.6  1.0 1.0E-02 1.7E-04 6.5 (m) 0.96 (c) - 5 (n) - 
Difenoconazole 70 ± 7  29 ± 6  2.4 1.3E-04 5.2E-06 - 4 (n) - 
Triadimenol 11 ± 0.7 26 ± 2 0.4 8.2E-04 5.8E-06 21 (m) 12.6 (p) - 
Fenarimol 6 ± 1 18 ± 6 0.3 1.5E-03 8.3E-06 4.1*** (q) - 10 (m) 2 (m, c) - 
Methylmercury 11 ± 1 0.78 ± 0.07  14.1 8.2E-04 1.9E-04 - - - 
RPAI: relative potency of aromatase inhibition, # = 80% of inhibition, ## = 100% of inhibition, * = roach brain microsomes, ** = S9 fraction from brain 
fathead minnow, *** = rat ovarian microsomes (a) France et al., 1987; (b) Geelen et al, 1991; (c) Ohno et al., 2004; (d) Yue and Brodie, 1997; (e) Shilling et 
al., 1999; (f) Pelissero et al., 1996; (g) Le Bail et al., 2000; (h) Zhao et al., 2001; (i) Ayub and Levell, 1990; (j) Mason et al;1987; (k) Monod et al., 1993; (l) 




Fig. 1. Effect of the amount of microsomal proteins and incubation time on the aromatase 
activities (AA) in rainbow trout ovaries (A) and brain (B). In all experiments, the 
concentration of substrate was 75 nM and the reaction was carried out at a temperature of 
27°C. Each value represents the mean of two independent experiments ± SD. 
 
Fig. 2. Saturation analysis of aromatase activity (AA) in : (A) ovarian microsomes, and (B) 
brain microsomes of rainbow trout. Brain and ovaries were incubated 30 min at 27°C with 
increasing concentrations of 1- [3H]-androstenedione from 2 to 600 nM. Inserts : 
Lineweaver-Burk plots to determine the Vmax and the Km. 
 
Fig. 3. Effect of temperature on the rainbow trout aromatase activities (AA) in brain (A) and 
ovary (B).The concentration of substrate was 75 nM and the amount of protein 200 µg. AA 
were expressed as percent of maximal AA measured for each tissue. 
 
Fig. 4. Effect of temperature on brain and ovarian IC50 values for two aromatase inhibiting 
substances (prochloraz and 4-hydroxyandrostenedione (4-OHA)). IC50 values calculated in 
ovary (A) and brain (B) for each substance at 18°C and 27°C were not significantly different 
(Student’s t test, p > 0.05). 
 
Fig. 5. Linear regression analysis between brain and ovarian LOG (IC50) values. Brain and 
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